tnf
highli
express
synovi
tissu
rheumatoid
arthriti
ra
patient
induc
proinflammatori
cytokin
secret
howev
case
tnf
caus
cell
death
consid
abnorm
prolifer
activ
rheumatoid
arthriti
synovioblast
proper
rate
synovioblast
apoptosi
could
possibl
reliev
arthriti
howev
mechan
mediat
tnfinduc
synovioblast
surviv
versu
cell
death
ra
fulli
understood
object
studi
role
tnf
downstream
pathway
prefer
ra
synovioblast
found
overexpress
tnf
synovi
tissu
increas
apoptot
level
vitro
tnfinduc
mild
synovioblast
apoptosi
promot
secret
highli
express
rheumatoid
arthriti
synovi
fibroblast
rasf
increas
resist
synovioblast
apoptosi
tnf
stimul
downregul
increas
apoptot
rate
inhibit
kinas
ikk
pathwaydepend
proinflammatori
cytokin
secret
determin
extracellular
portion
intracellular
portion
respons
synovioblast
apoptosi
resist
monoclon
antibodi
inhibit
tnfinduc
proinflammatori
cytokin
product
effect
apoptot
rate
thu
studi
indic
resist
tnfinduc
apoptosi
promot
pathway
extracellular
portion
function
region
rheumatoid
arthriti
ra
chronic
autoimmun
inflammatori
diseas
sever
inflammatori
symptom
joint
mostli
hand
feet
knee
ra
affect
approxim
popul
high
incid
women
old
peopl
abnorm
accumul
fibroblast
macrophag
lymphocyt
synovi
joint
final
caus
destruct
bone
cartilag
rheumatoid
arthriti
synovi
fibroblast
rasf
regard
direct
induc
damag
receiv
molecular
signal
macrophag
lymphocyt
secret
metalloproteinas
mmp
granulocytemacrophag
colonystimul
factor
gmcsf
among
other
one
import
upstream
signal
rasf
tnf
highli
express
cytokin
serum
synovium
ra
patient
tnf
type
ii
transmembran
homotrim
releas
solubl
form
proteolyt
cleavag
tnfconvert
enzym
tace
mainli
secret
synovi
macrophag
tnf
consid
import
factor
pathogenesi
rheumatoid
arthriti
caus
intract
inflamm
joint
infliximab
tnf
antibodi
alreadi
prove
effect
treat
ra
patient
howev
differ
cell
type
variou
activ
state
varieti
microenviron
factor
tnf
contribut
either
proinflammatori
cytokin
secret
cell
death
tnf
receptor
known
one
death
receptor
receiv
death
signal
given
tnf
ligand
induc
caspasedepend
apoptosi
caspaseindepend
necroptosi
type
program
necrosi
apoptot
rate
rasf
tnf
stimul
could
signific
could
decreas
number
effect
rasf
inhibit
tnfrelat
immun
activ
two
differ
downstream
signal
pathway
cell
surviv
versu
caspaserel
apoptosi
tnf
signal
could
influenc
certain
import
molecul
help
switch
differ
pattern
although
tnf
studi
long
time
mechan
underli
downstreampattern
prefer
still
unclear
elucid
tnfrelat
cell
death
pathway
synovioblast
increas
understand
ra
may
suggest
treatment
also
call
extracellular
matrix
metalloproteinas
induc
emmprin
leukocyt
activationassoci
antigen
transmembran
glycoprotein
receptor
cyclophilin
cypa
contribut
tumor
metastasi
inflamm
pathogen
plasmodium
falciparum
coronaviru
infect
previou
work
proven
upregul
ra
synoviocyt
includ
rasf
macrophagelik
cell
overexpress
increas
mmp
product
invas
synoviocyt
addit
rasf
induc
upregul
vegf
promot
angiogenesi
synovium
caus
persist
synov
monoclon
antibodi
inhibit
cartilag
eros
synov
scid
mous
model
rheumatoid
arthriti
howev
far
role
tnfinduc
rasf
apoptosi
studi
report
hepatocellular
carcinoma
hcc
inhibit
hcc
cell
apoptosi
endoplasm
reticulum
er
stress
other
shown
tnf
key
cross
talk
er
stress
oxid
stress
data
highlight
possibl
play
neg
role
tnfrelat
apoptosi
report
investig
function
tnf
signal
pathway
prefer
ra
synovioblast
attempt
identifi
function
region
respons
prefer
twentyf
ra
patient
osteoarthr
oa
patient
involv
experi
inform
consent
obtain
patient
ra
oa
satisfi
diagnost
criteria
american
colleg
rheumatolog
mean
age
ra
patient
year
rang
year
mean
age
oa
patient
year
rang
year
femal
synovi
tissu
obtain
ra
oa
patient
joint
arthroscopi
xije
hospit
xian
china
ethic
approv
studi
grant
ethic
committe
fourth
militari
medic
univers
primari
ra
synovi
fibroblast
synoviocyt
b
isol
synovium
ra
patient
follow
manner
previous
describ
pure
biolog
function
fibroblast
primari
fibroblast
use
third
fifth
passag
rasf
cultur
dmem
highglucos
medium
fetal
bovin
serum
regular
cultur
condit
translentivir
plko
system
use
construct
stabl
knockdown
synovioblast
rasf
rasf
nc
rasf
transfect
lentiviru
without
short
hairpin
rna
shrna
sequenc
construct
lentiviru
carri
shrna
describ
previous
name
plasmid
translentivir
plko
system
ml
plko
transfect
hek
cell
medium
contain
lentiviru
hek
cell
collect
cultur
rasf
puromycin
sigma
buch
switzerland
ad
medium
select
day
success
transfect
rasf
rasf
nc
cell
resist
puromycin
blank
control
group
rasf
ctl
cell
kill
puromycin
concentr
obtain
stabl
cell
clone
rasf
rasf
nc
cell
maintain
medium
contain
puromycin
least
week
vector
pcdna
use
carri
full
length
extracellular
portion
intracellular
portion
exogen
amino
acid
extracellular
portion
intracellular
portion
contain
transmembran
region
shrna
sequenc
target
region
messeng
rna
mrna
inhibit
exogen
extracellular
portion
intracellular
portion
express
contain
sequenc
transfect
follow
instruct
lipofectamin
invitrogen
basel
switzerland
concentr
vector
cell
test
use
h
transfect
synovi
tissu
immunohistochem
stain
perform
use
streptavidinperoxidas
kit
zyme
san
diego
usa
primari
antibodi
antitnf
mous
mab
proteintech
wuhan
china
mous
mab
prepar
laboratori
final
concentr
anticleavedcaspas
rabbit
polyclon
ab
cell
signal
danver
usa
primari
antibodi
incub
overnight
section
react
biotinlabel
goat
antimouserabbit
igg
horseradish
peroxidaselabel
streptavidin
diaminobenzidin
zyme
san
diego
usa
respect
nuclei
restain
hematoxylin
irrelev
mous
antihuman
igg
biolegend
san
diego
usa
rabbit
serum
use
neg
control
tnf
cleavedcaspas
quantit
analysi
perform
imagepro
plu
version
softwar
three
random
field
section
visual
averag
number
cleavedcaspas
cell
three
field
consid
valu
posit
averag
integr
optic
densiti
summari
iod
sum
use
measur
tnf
express
cell
attach
glass
coverslip
h
coverslip
place
plate
tnf
r
system
abingdon
uk
treatment
h
cell
fix
formaldehyd
pb
permeabil
triton
min
block
goat
serum
pb
h
coverslip
incub
prepar
laboratori
final
concentr
cleavedcaspas
cell
signal
danver
usa
antibodi
h
cell
wash
pb
incub
correspond
fitc
apc
secondari
antibodi
thermo
scientif
rockford
usa
h
nuclei
stain
dapi
final
cell
detect
nikon
fluoresc
microscop
flow
cytometri
assay
express
rasf
detect
flow
cytometri
previous
describ
assess
apoptosi
tnfstimul
unstimul
cell
collect
wash
pb
stain
annexin
v
propidium
iodid
pi
annexin
vfitc
apoptosi
detect
kit
millipor
boston
usa
follow
instruct
cell
analyz
facscalibur
flow
cytometri
bd
pharmingen
san
diego
usa
data
process
use
flowjo
softwar
differ
treatment
mrna
rasf
isol
ezna
total
rna
kit
ii
omega
biotek
norcross
usa
rnasefre
condit
revers
transcript
mrna
use
takara
primescript
rt
reagent
kit
follow
manufactur
instruct
realtim
quantit
rtpcr
system
includ
follow
sybr
takara
otsu
japan
primer
forward
revers
primer
cdna
templat
ddh
gapdh
mrna
use
normal
target
mrna
rel
quantiti
experi
automat
calcul
compar
quantit
mode
mxpro
qpcr
system
softwar
least
three
independ
experi
perform
analyz
rel
express
ratio
control
mrna
primer
sequenc
hugapdh
forward
hugapdh
revers
forward
revers
forward
revers
forward
revers
forward
revers
forward
revers
forward
revers
huikk
forward
c
c
g
g
g
h
u
k
k
r
e
v
e
r
e
g
c
g
g
serumfre
medium
rasf
sampl
collect
centrifug
min
releas
rasf
cultur
medium
directli
measur
human
elisa
kit
human
elisa
kit
dakew
shenzhen
china
accord
manufactur
instruct
optic
densiti
determin
biorad
micropl
reader
absorpt
measur
nm
standard
curv
measur
establish
use
cytokin
standard
provid
elisa
kit
western
blot
assay
rasf
ctl
rasf
nc
rasf
cell
treat
tnf
tpck
collect
use
ripa
biotim
h
n
g
h
c
h
n
w
h
p
r
e
e
n
h
b
r
n
phenylmethanesulfonyl
fluorid
pmsf
biotim
shanghai
china
ice
min
centrifug
supernat
protein
concentr
determin
bicinchonin
acid
thermo
scientif
rockford
usa
protein
assay
sdspage
gel
use
separ
protein
protein
transfer
pvdf
membran
blot
probe
h
primari
antibodi
dilut
trisbuff
salin
tb
contain
nonfat
milk
dilut
antibodi
final
concentr
dilut
antibodi
final
concentr
dilut
rela
ikk
antibodi
proteintech
wuhan
china
secondari
antibodi
goat
antimous
antibodi
goat
antirabbit
antibodi
thermo
scientif
rockford
usa
incub
pvdf
membran
h
room
temperatur
visual
realiz
enhanc
chemiluminesc
ecl
western
blot
detect
system
experi
perform
independ
least
three
time
data
express
mean
valu
sd
unpair
pair
test
oneway
analysi
varianc
follow
dunnett
posttest
subgroup
analys
use
analys
made
use
spss
statist
softwar
packag
statist
imag
process
graphpad
prism
softwar
bonferroni
correct
appli
number
hypothes
made
n
differ
consid
statist
signific
p
studi
apoptosi
ra
patient
synovium
first
monitor
tnf
express
ra
synovium
tissu
stain
display
patholog
chang
ra
oa
synovi
tissu
fig
immunohistochemistri
irrelev
mous
antihuman
igg
rabbit
serum
use
neg
control
fig
section
differ
patient
show
tnf
overexpress
ra
synovium
remain
rel
low
level
oa
fig
stain
cleavedcaspas
reveal
obviou
differ
ra
oa
synovium
tissu
fig
indic
overexpress
tnf
ra
synovium
caus
extra
apoptosi
vitro
examin
tnfinduc
synovioblast
apoptosi
treat
tnf
ngml
h
apoptot
rasf
annexin
v
posit
increas
time
normal
level
fig
b
assess
apoptosi
rasf
treat
tnf
time
cours
rate
apoptot
rasf
fluctuat
begin
reach
maximum
valu
h
fig
tnf
concentr
increas
ngml
apoptot
rasf
accordingli
increas
fig
realtim
pcr
result
demonstr
mrna
express
chang
tnf
treatment
highest
h
fig
f
analyz
mechan
tnfrelat
synovioblast
apoptosi
resist
detect
express
n
n
r
n
n
v
l
u
e
f
g
immunohistochem
stain
reveal
upregul
ra
synovium
use
lentiviru
knockdown
express
rasf
western
blot
flow
cytometri
result
indic
lentiviru
disabl
protein
express
rasf
realtim
pcr
show
downregul
mrna
rasf
fig
rasf
nc
refer
lentiviru
transfect
without
inhibit
express
rasf
ctl
repres
rasf
without
lentiviru
transfect
next
treat
rasf
ctl
nc
cell
tnf
ngml
h
downregul
rasf
significantli
enhanc
tnfinduc
apoptosi
wherea
rasf
ctl
rasf
nc
cell
apoptosi
remain
rel
low
rate
fig
immunofluoresc
assay
indic
fluoresc
markedli
lower
rasf
stain
illustr
downregul
significantli
enhanc
tnfinduc
apoptosi
fig
f
transfect
fulllength
pcdna
rasf
neg
control
rasf
nc
plasmid
primari
rasf
western
blot
result
indic
success
overexpress
fig
transfect
tnfinduc
apoptosi
significantli
differ
rasf
nc
rasf
fig
test
contribut
tnfinduc
apoptosi
resist
examin
relationship
cytokin
express
express
tnftreat
nptosyllphenylalanin
chloromethyl
keton
tpck
inhibitor
final
concentr
sigma
buch
switzerland
treat
synovioblast
realtim
pcr
result
demonstr
express
decreas
lentiviru
transfect
downregul
group
inhibit
mrna
express
tnf
treatment
reveal
obviou
differ
treat
tnf
inhibitor
tpck
fig
western
blot
assay
demonstr
downregul
decreas
kinas
ikk
protein
level
meanwhil
use
rela
antibodi
found
three
main
band
around
kd
rela
kd
complex
kd
complex
rasf
kd
complex
band
much
stronger
rasf
ctl
rasf
nc
indic
probabl
play
role
collaps
complex
fig
c
addit
downregul
rasf
significantli
enhanc
tnfinduc
apoptosi
howev
downregul
made
differ
apoptot
rate
use
tnf
inhibitor
tpck
fig
e
ikk
mrna
express
decreas
group
illustr
posit
regul
ikk
transcript
fig
extracellular
portion
respons
synovioblast
apoptosi
resist
transfect
extracellular
intracellular
portion
ep
ip
rasf
knockdown
cell
fig
realtim
pcr
result
indic
compar
oa
scale
b
lentiviru
transfect
success
knock
mrna
protein
express
approxim
origin
express
proven
realtim
pcr
western
blot
flow
cytometri
c
repres
flow
cytometri
result
statist
analysi
tnfinduc
ngml
h
apoptosi
rasf
ctl
rasf
nc
rasf
cell
annexin
vposit
dot
indic
assist
synovioblast
apoptosi
resist
tnf
stimul
e
f
repres
immunofluoresc
pictur
statist
analysi
tnfinduc
ngml
h
apoptosi
posit
white
arrow
express
scale
g
transfect
fulllength
express
rasf
measur
western
blot
h
repres
flow
cytometri
result
statist
analysi
tnfinduc
ngml
h
apoptosi
rasf
nc
rasf
p
p
p
n
ns
signific
rasf
group
rasf
cell
express
extracellular
portion
mrna
wherea
rasf
group
express
intracellular
portion
mrna
western
bolt
flow
cytometri
result
indic
extracellular
portion
success
express
cell
membran
fig
howev
owe
lack
proper
antibodi
get
proof
intracellular
portion
protein
rasf
tnfinduc
apoptosi
fig
knockdown
inhibit
pathway
activ
tnf
stimul
rel
mrna
express
measur
realtim
pcr
tnf
andor
tpck
stimul
b
c
repres
result
statist
analysi
ikk
rel
complex
protein
express
western
blot
assay
tnf
andor
tpck
stimul
e
repres
result
statist
analysi
apoptosi
induc
tnf
andor
tpck
f
rel
ikk
mrna
express
measur
realtim
pcr
tnf
andor
tpck
stimul
p
p
p
ns
signific
reduc
rasf
group
rasf
group
fig
suggest
extracellular
portion
respons
tnfinduc
apoptosi
resist
rasf
monoclon
antibodi
prepar
laboratori
previous
shown
inhibit
proinflammatori
cytokin
secret
lymphocyt
ad
mab
tnftreat
rasf
assess
role
antibodi
apoptosi
cytokin
secret
apoptot
rasf
increas
tnf
treatment
obviou
chang
mab
ad
fig
b
realtim
pcr
data
indic
neg
role
mab
tnfinduc
mrna
express
fig
elisa
result
support
inhibitori
effect
secret
fig
tnf
overexpress
signific
signatur
ra
detect
serum
synovi
fluid
tnf
respons
immun
activ
lymphocyt
b
lymphocyt
fibroblast
endothelium
cell
macrophag
promot
secret
cytokin
turn
caus
intract
inflamm
infliximab
tnf
antibodi
alreadi
proven
effect
treat
ra
patient
howev
case
tnf
also
known
induc
apoptosi
necroptosi
apoptosi
domin
physiolog
cell
death
play
import
role
individu
develop
respond
mild
stress
contrast
necroptosi
rasf
denot
extracellular
portion
express
rasf
rasf
denot
intracellular
portion
express
rasf
western
blot
flow
cytometri
result
ep
protein
express
c
repres
result
statist
analysi
flow
cytometri
assay
illustr
extracellular
portion
could
revers
resist
tnfstimul
apoptosi
rasf
cell
p
p
p
ns
signific
program
type
necrosi
common
patholog
condit
unlik
necrosi
apoptot
cell
produc
apoptot
bodi
remov
quickli
without
damag
synovium
ra
patient
high
express
tnf
greatli
enhanc
potenti
tnfrelat
synovioblast
apoptosi
proper
degre
rasf
apoptosi
one
thing
allevi
bone
cartilag
eros
reduc
number
fibroblast
anoth
consum
tnf
would
otherwis
caus
extra
immun
respons
studi
found
tnf
express
correl
apoptot
rate
ra
oa
synovi
tissu
remain
rel
low
level
tnf
caus
mild
apoptosi
vitro
key
question
tnf
signal
pattern
prefer
ra
synovium
cell
surviv
pathway
caspaserel
apoptosi
pathway
factor
contribut
tnf
signal
pattern
prefer
includ
concentr
tnf
time
cours
tnf
stimul
express
import
molecul
high
level
long
durat
tnf
express
serum
synovium
ra
patient
proven
clinic
studi
nevertheless
littl
known
vital
molecul
switch
tnf
signal
differ
pattern
transmembran
protein
origin
found
hepatocyt
cancer
biomark
facilit
mmp
product
increas
invas
hepatocellular
carcinoma
similarli
ra
synoviocyt
promot
eros
bone
cartilag
moreov
overexpress
rasf
result
angiogenesi
synovium
even
though
indic
tnfstimul
rasf
confirm
inhibit
hcc
cell
apoptosi
er
stress
hand
tnf
signific
er
stress
suggest
may
vital
protect
cell
tnfstimul
apoptosi
result
indic
first
time
one
molecul
caus
cell
surviv
pathway
prefer
apoptosi
pathway
tnf
activ
final
caus
apoptosi
resist
rasf
though
previou
studi
testifi
activ
role
recombin
human
exogen
stimul
cardiomyocyt
first
time
reveal
downregul
rasf
could
inhibit
ikk
transcript
protein
express
demonstr
could
direct
transcript
factor
ikk
regul
ikk
transcript
factor
possibl
mechan
inflammatori
activ
apoptosi
resist
increas
ikk
transcript
fig
rasf
monoclon
antibodi
inhibit
tnfinduc
proinflammatori
cytokin
product
influenc
apoptot
rate
repres
data
tnfinduc
apoptosi
could
amplifi
mab
b
statist
analysi
tnfinduc
apoptosi
illustr
mab
affect
tnfinduc
cell
apoptosi
c
inhibitori
role
mab
tnfrelat
cytokin
product
elisa
result
show
secret
lower
group
tnf
group
p
p
ns
signific
protein
express
complex
easier
collaps
tnf
stimul
result
ra
synovium
high
level
tnf
pathway
rasf
activ
meanwhil
apoptosi
pathway
block
region
function
rasf
tnfrelat
inflammatori
activ
apoptosi
resist
find
extracellular
portion
play
major
role
block
function
extracellular
portion
use
monoclon
antibodi
fail
allevi
tnfrelat
apoptosi
resist
indic
antigenantibodi
bind
site
contribut
resist
howev
direct
molecul
interact
extracellular
portion
mechan
ikk
transcript
activ
still
unknown
research
intracellular
portion
relat
synovioblast
apoptosi
resist
although
intracellular
portion
detect
mrna
level
could
exclud
possibl
unsuccess
protein
express
ip
exogen
protein
easili
degrad
difficult
detect
therefor
concret
mechan
intracellular
portion
still
need
explor
summari
first
time
proven
respons
apoptosi
resist
rasf
tnf
stimul
studi
clarifi
one
mechan
tnfrelat
ra
pathogenesi
shed
light
potenti
ra
treatment
target
inflammatori
activ
apoptosi
resist
